Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jos J Jager

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 19, 2006
Prone breast irradiation for pendulous breastsJeroen Buijsen, Jos J Jager, Janneke Bovendeerd, et al.
Acta Oncologica (Stockholm, Sweden)|December 19, 2009
FDG-PET-CT for staging of high-risk breast cancer patients reduces the number of further examinations: A pilot studyJos J Jager, Kristien Keymeulen, Regina G H Beets-Tan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 13, 2006
Radiation-induced bullous pemphigoid: a systematic review of an unusual radiation side effectVeronique E M Mul, Adrienne J van Geest, Madelon C G Pijls-Johannesma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2007
Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trialHarry Bartelink, Jean-Claude Horiot, Philip M Poortmans, et al.
Practical Radiation Oncology|November 30, 2014
Set-up verification and 2-dimensional electronic portal imaging device dosimetry during breath hold compared with free breathing in breast cancer radiation therapyPatricia J A M Brouwers, Tim Lustberg, Jacques H Borger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Impact of pathological characteristics on local relapse after breast-conserving therapy: a subgroup analysis of the EORTC boost versus no boost trialHeather A Jones, Ninja Antonini, Augustinus A M Hart, et al.
European Journal of Cancer (Oxford, England : 1990)|September 2, 2008
Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer: a study based on the EORTC Trial 22881-10882 'boost versus no boost'Sandra Collette, Laurence Collette, Tom Budiharto, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 19, 2006
Prone breast irradiation for pendulous breastsJeroen Buijsen, Jos J Jager, Janneke Bovendeerd, et al.
Acta Oncologica (Stockholm, Sweden)|December 19, 2009
FDG-PET-CT for staging of high-risk breast cancer patients reduces the number of further examinations: A pilot studyJos J Jager, Kristien Keymeulen, Regina G H Beets-Tan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 13, 2006
Radiation-induced bullous pemphigoid: a systematic review of an unusual radiation side effectVeronique E M Mul, Adrienne J van Geest, Madelon C G Pijls-Johannesma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2007
Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trialHarry Bartelink, Jean-Claude Horiot, Philip M Poortmans, et al.
Practical Radiation Oncology|November 30, 2014
Set-up verification and 2-dimensional electronic portal imaging device dosimetry during breath hold compared with free breathing in breast cancer radiation therapyPatricia J A M Brouwers, Tim Lustberg, Jacques H Borger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Impact of pathological characteristics on local relapse after breast-conserving therapy: a subgroup analysis of the EORTC boost versus no boost trialHeather A Jones, Ninja Antonini, Augustinus A M Hart, et al.
European Journal of Cancer (Oxford, England : 1990)|September 2, 2008
Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer: a study based on the EORTC Trial 22881-10882 'boost versus no boost'Sandra Collette, Laurence Collette, Tom Budiharto, et al.
Pageof 1